Clinical Outcome in Uveitis
Launched by MOORFIELDS EYE HOSPITAL NHS FOUNDATION TRUST · Nov 13, 2013
Trial Information
Current as of April 30, 2025
Completed
Keywords
ClinConnect Summary
Patients will be included if they are treated for uveitis and have had repeat follow-up. Data will be gathered from the entire length of the patients follow-up.
The main outcome measures will be:
Change from baseline of Best corrected visual acuity (BCVA)at 10 years Causes of vision loss (≤6/15, VL) and severe vision loss (≤6/60, SVL) at 10 years Number of clinical visits at 10 years.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Clinical Diagnosis of Uveitis.
- Exclusion Criteria:
- • No follow-up data.
About Moorfields Eye Hospital Nhs Foundation Trust
Moorfields Eye Hospital NHS Foundation Trust is a leading specialist eye hospital located in London, renowned for its commitment to advancing ophthalmic research and clinical care. As a prominent clinical trial sponsor, Moorfields is dedicated to improving patient outcomes through innovative research, employing cutting-edge technology and methodologies in the field of ophthalmology. The institution collaborates with a diverse range of partners, including academic institutions and industry stakeholders, to facilitate groundbreaking studies aimed at developing new treatments and therapies for various eye conditions. With a strong focus on patient safety and ethical standards, Moorfields Eye Hospital remains at the forefront of eye care, driving progress in the understanding and management of visual impairments.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
London, , United Kingdom
Patients applied
Trial Officials
Sue Lightman, PhD,FRCOphth
Principal Investigator
Moorfields Eye Hospital NHS Foundation Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials